ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2012 ACR/ARHP Annual Meeting

November 9-14, 2012 in Washington, DC

View by Title View Sessions
  • ACR Late-breaking Abstract Oral Session
  • ACR Late-breaking Abstracts Poster Session
  • ACR/ARHP Combined Epidemiology Abstract Session
  • ACR/ARHP Combined Rehabilitation Abstract Session
  • ACR/REF Edmond L. Dubois, MD Memorial Lectureship: Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients
  • Antiphospholipid Syndrome
  • B-cell Biology and Targets in Autoimmune Disease
  • Biology and Pathology of Bone and Joint
  • Biology and Pathology of Bone and Joint: Osteoarthritis
  • Biology and Pathology of Bone and Joint: Regulation of Bone Cells
  • Care of Patients With Rheumatoid Arthritis
  • Cell-cell Adhesion, Cell Trafficking and Angiogenesis
  • Clinical Practice/Patient Care
  • Clinical and Rehabilitative Aspects of Osteoarthritis
  • Cytokines, Mediators, and Gene Regulation
  • Cytokines, Mediators, and Gene Regulation I
  • Cytokines, Mediators, and Gene Regulation II
  • Education/Community Programs
  • Epidemiology and Health Services Research I: Epidemiology and Outcomes in Rheumatic Disease
  • Epidemiology and Health Services Research II: Epidemiologic Risk Factors in the Development of Rheumatic Disease
  • Epidemiology and Health Services Research III: Rheumatic Diseases and Cardiovascular Disease and Risk Assessment
  • Epidemiology and Health Services Research IV: Outcomes and Costs in Rheumatic Disease
  • Epidemiology and Health Services Research V: Rheumatoid Arthritis Management in the Treat-to-Target Era
  • Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease I
  • Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II
  • Epidemiology and Health Services Research: Rheumatic Disease Pharmacoepidemiology
  • Epidemiology and Public Health
  • Factors Associated with Rheumatoid Arthritis
  • Fibromyalgia and Soft Tissue Disorders
  • Fibromyalgia and Soft Tissue Disorders I
  • Fibromyalgia and Soft Tissue Disorders II
  • Foot and Gait Disorders
  • Genetics and Genomics of Rheumatic Diseases
  • Imaging of Rheumatic Diseases I: Ultrasound and X-ray
  • Imaging of Rheumatic Diseases II: Magnetic Resonance Imaging
  • Imaging of Rheumatic Diseases III: Computed Tomography
  • Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray
  • Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging
  • Infection-related Rheumatic Disease
  • Innate Immunity and Rheumatic Disease
  • Medical Education
  • Metabolic and Crystal Arthropathies
  • Metabolic and Crystal Arthropathies: Basic Science
  • Metabolic and Crystal Arthropathies: Clinical
  • Miscellaneous Rheumatic and Inflammatory Diseases
  • Miscellaneous Rheumatic and Inflammatory Diseases: Periodic Fever Syndromes
  • Miscellaneous Rheumatic and Inflammatory I
  • Muscle Biology, Myositis and Myopathies: Classification, Treatment and Outcome in Idiopathic Inflammatory Myopathies
  • Muscle Biology, Myositis and Myopathies: Clinical and Therapuetic Aspects of Idiopathic Inflammatory Myopathies
  • Muscle Biology, Myositis and Myopathies: Genetics, Autoantibodies and other Molecular Aspects of Idiopathic Inflammatory Myopathies and Models
  • Muscle Biology, Myositis and Myopathies: Pathogenesis in Idiopathic Inflammatory Myopathies
  • Orthopedics, Low Back Pain, and Rehabilitation
  • Osteoarthritis
  • Osteoarthritis - Clinical Aspects
  • Osteoarthritis - Clinical Aspects I: Weight, Activity, and Metabolic Effects on Osteoarthritis
  • Osteoarthritis - Clinical Aspects II: Structural Risks for Osteoarthritis End-points and Potential Treatments
  • Osteoporosis and Metabolic Bone Disease
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
  • Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis
  • Pediatric Rheumatology - Pathogenesis and Genetics
  • Pediatric Rheumatology: Clinical and Therapeutic Disease I: Juvenile Idiopathic Arthritis I
  • Pediatric Rheumatology: Clinical and Therapeutic Disease II: Juvenile Idiopathic Arthritis II
  • Pediatric Rheumatology: Clinical and Therapeutic Disease III: Childhood Systemic Lupus Erythematosus and Other Vasculidities
  • Pediatric Rheumatology: Clinical and Therapeutic Disease IV: Childhood Therapeutics and Response
  • Pediatrics
  • Pediatrics: Disease Flares
  • Physical/Occupational Therapy and Exercise in Patients with Rhematologic Disease
  • Plenary Session I: Discovery 2012
  • Plenary Session II: Discovery 2012
  • Plenary Session III: Discovery 2012
  • Programs and Literacy in Patients with Rheumatologic Diseases
  • Psychological Aspects of Rheumatologic Disease
  • Psychology/Social Sciences
  • Quality Measures and Innovations in Practice Management and Care Delivery
  • Rehabilitation Sciences
  • Rheumamtoid Arthritis - Human Etiology and Pathogenesis
  • Rheumatoid Arthritis - Clinical Aspects I: Drug Studies/Drug Safety/Drug Utilization/Disease Activity & Remission
  • Rheumatoid Arthritis - Clinical Aspects I: Risk Factors and Prediction of Rheumatoid Arthritis
  • Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease
  • Rheumatoid Arthritis - Clinical Aspects II: Long-term Outcome of Rheumatoid Arthritis, Observational Studies
  • Rheumatoid Arthritis - Clinical Aspects III: Infections/Risk Factors for Incident Rheumatoid Arthritis/Metrology/Classification/Biomarkers/Predictors of Rheumatolid Arthritis Activity & Severity
  • Rheumatoid Arthritis - Clinical Aspects III: Rheumatoid Arthritis and Cardiovascular Disease
  • Rheumatoid Arthritis - Clinical Aspects IV: Non-biologic Drugs for Rheumatoid Arthritis: New Insights on Comorbidities and Adverse Events
  • Rheumatoid Arthritis - Clinical Aspects V: Comorbidities in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Clinical Aspects VI: Remission and Flare in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Clinical Aspects VII: Prediction of Outcome in Rheumatoid Arthritis
  • Rheumatoid Arthritis - Human Etiology and Pathogenesis I: Early Pathogenesis of Rheumatoid Arthritis
  • Rheumatoid Arthritis - Human Etiology and Pathogenesis II: Cellular Effectors of Rheumatoid Arthritis and Novel Rheumatoid Arthritis Genome-Wide Association Studies
  • Rheumatoid Arthritis - Human Etiology and Pathogenisis
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Comparative Efficacy and Novel Treatment Strategies in Rheumatoid Arthritis
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Efficacy and Safety of Novel Entities
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Efficacy of Approved Biologics
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Safety & Efficacy of Janus Activated-Kinase (JAK) Inhibitors
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Safety I
  • Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene Therapy: Safety II
  • Rheumatoid Arthritis: Animal Models
  • Sjögren's Syndrome - Clinical
  • Sjögren's Syndrome - Pathogenesis
  • Sjögren's Syndrome I - Pathogenesis
  • Sjögren's Syndrome II - Clinical
  • Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology
  • Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Psoriatic Arthritis
  • Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Psoriatic Arthritis and Spondyloarthritis
  • Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Spondyloarthritis I
  • Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Spondyloarthritis II
  • Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment
  • Spondyloarthritis and Psoriatic Arthritis - Pathogenesis, Etiology
  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus - Animal Models
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment I: Renal
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment II: Clinical Aspects/Pregnancy
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment III: Cardiovascular
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment IV: Therapeutics
  • Systemic Lupus Erythematosus - Clinical Aspects and Treatment V: Clinical Aspects
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis I
  • Systemic Lupus Erythematosus - Human Etiology and Pathogenesis II
  • Systemic Lupus Erythematosus: Clinical Aspects
  • Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s – Pathogenesis, Animal Models and Genetics
  • Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics
  • Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics I
  • Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics II
  • Systemic Sclerosis, Vasculitis, Crohn's and Spondylarthropathies
  • T-cell Biology and Targets in Autoimmune Disease
  • Vasculitis
  • Vasculitis: Clinical Aspects
  • Vasculitis: Clinical Trials
  • Vasculitis: Pathogenesis
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.